Health and Me

Tanya Dutt

NHS Approves First-Ever Daily Pill For Endometriosis, Could Replace Injections

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS in England. This marks a significant advancement in the treatment of a condition that impacts an estimated 1.5 million women in the UK. The new drug, relugolix-estradiol-norethisterone (relugolix combination therapy or Ryeqo), offers a more comfortable and less stressful option compared to current treatments. But it will be accessible to only those patients who have already tried every alternative.

Endometriosis is a long-term condition in which tissue that's like the womb lining grows somewhere else in the body, often in the pelvis, bladder, and bowel. This ectopic tissue, like normal endometrial tissue, thickens, breaks down, and bleeds during each menstrual cycle, but without a means of exit from the body. This activity causes intense inflammation, scarring, and the development of adhesions that can lead to intense pain and fertility issues.

The condition is also legendary for its late diagnosis, with the majority of women taking nine years on average to receive an official diagnosis. Symptoms tend to be wrongly diagnosed as other conditions such as fibroids, pelvic inflammatory disease, or irritable bowel syndrome (IBS), so early detection is not always easy.

Symptoms of endometriosis are likely to include:

<ul><li>Severe period pain that interferes with daily life</li><li>Heavy menstrual bleeding</li><li>Painful urination or bowel movements</li><li>Lower abdominal pain in a chronic form</li><li>Painful sex</li><li>Fatigue and breathlessness</li><li>Mood swings, anxiety, and depression</li><li>Trouble conceiving</li></ul>

In contrast to existing injectable therapies that necessitate regular clinic visits, the newly approved pill provides a more convenient option for treating endometriosis at home. Relugolix combination therapy functions by inhibiting certain hormones that drive endometriosis growth while also offering required hormone replacement to offset side effects.

Conventional injectable medications have the potential to aggravate symptoms initially before they bring relief, and thus complicate the treatment process for patients. Ryeqo works faster and reduces the use of multiple drugs, which streamlines the treatment process. Patients no longer need to visit hospitals and clinics repeatedly as they can take a pill daily. Physical as well as psychological stress is also minimized.

<h2>Who Can Benefit from the New Treatment?</h2>

Although promising, the new pill will only be offered to women who have already attempted and failed other medical or surgical interventions for endometriosis. It is predicted that about 1,000 women per year will receive this treatment on the NHS.

Aside from addressing endometriosis, Ryeqo has also been approved by NICE for treating moderate to severe symptoms of uterine fibroids, another condition that affects numerous women.

Helen Knight, NICE director of medicines evaluation, underlined the significance of this approval, saying, "This new treatment represents a potential step-change in the management of endometriosis, returning control to patients while maintaining value for the taxpayer."

The release of this pill is a welcome relief, as women with endometriosis often have limited treatment options available to them. Today, managing the condition typically consists of pain killers, hormonal therapies, and, in extreme cases, operations like laparoscopies or hysterectomies.

NHS national clinical director for women's health Dr. Sue Mann emphasized the pill's benefits, saying, "This first-of-a-kind treatment for endometriosis – a condition which can be hugely debilitating – will give women more control over their own health by potentially enabling them to receive the treatment they require in the privacy of their own homes, without the necessity of going to regular appointments."

<h2>Cost and Availability of the Pill</h2>

The treatment is priced at £72 for a 28-day supply (VAT excluded). Although the cost appears high, the long-term advantages of minimizing hospital consultations and enhancing patients' quality of life make it an economical intervention in the wider healthcare context.

The pill will be accessible via standard NHS commissioning, thereby allowing those who qualify to use it without incurring extra financial costs.

<h2>What This Means for Women's Health?</h2>

The approval of Ryeqo is a welcome step in the right direction, but it also points to the continuing issues in <span>endometriosis treatment</span>. There are still many women who experience long delays in diagnosis and treatment, and there is an urgent need for more research, awareness, and funding for improved solutions.

Although this new pill will not cure endometriosis, it is a step in the right direction for making the disease more manageable and enhancing the quality of life for thousands of women. As medicine develops further, the desire would be for treatments to be more inclusive and accessible, eventually leading to improved outcomes for those suffering from endometriosis.

For women suffering from endometriosis, the approval of this new daily pill is a ray of hope. Reducing the necessity for the need of invasive procedures and numerous doctor visits, it enables patients to get in control of their well-being in a more convenient manner. Nevertheless, ongoing advocacy and studies have to be present to ensure that all women who suffer from the same condition get the care and treatment they need.

Health Conditions A-Z

health

menstrual health

endometriosis treatment

new endometriosis pill

nhs endometriosis care

relugolix therapy

endometriosis symptoms

hormonal treatment for endometriosis

ryeqo pill

Slushie Drinks Are Not Safe For Children, Finds Study

Common Sitting Mistakes That Make People Prone To Diseases

Breast Cancer Death Rates Will Drop In EU And UK In 2025

Health News

10 Desk Exercises To Keep You Active

10 Exercises To Help You Do Push-Ups Properly

10 Home Exercises For Core Strength

10 Exercises To Help You Relieve Back Pain

10 Low-Sodium Dinner Options You Must Try

10 Health Benefits Of Star Anise

10 Ways To Recover Quickly After Working Out

10 Low-Sodium Healthy Heart Snack

10 Bedtime Habits To Help You Lose Weight

10 Low Carb Lunch Options You Must Try

10 Foods to Avoid Eating During Season

10 Strength Exercises To Help You Burn Belly Fat

10 Food Habits That Are Ruining Your Health

10 Exercises You Should Do For Better Joint Health

10 Foods That Are High-Protein You May Not Know About

10 Fiber Rich Dinner Choices To Try

10 Ways To Curb Unhealthy Cravings

10 Healthy Egg Recipes You Can Try

​10 Morning Exercises You Should Do Everyday​

10 Protein Healthy Bread Recipes

10 Morning Habit You Should Teach Children

10 Nutty Recipes You Should Try For Your Health

10 Exercises You Should Do Before Sleeping

10 Exercises You Should Do For Arm Strength

10 Ways You Can Maximize Your Gym Exercises

10 Exercises You Can Do While Walking

10 Healthy Savoury Pancakes To Have For Breakfast

10 Herbal Tea Mixes For Winters

10 Habits To Ensure Your Teeth Health

10 Detox Juices You Should Try

10 Low Impact Exercises For Weight Loss

10 Foods That Should Be Part Of A Runners Diet

10 Gym Exercises Basketball Players Should Do

10 Light Foods You Can Eat Before Exercises

10 Ways To Beat The Sleep Spell In Office

10 Tips To Help Muscle Recovery

6-6-6 Walking Routine Can Help You Stay Fit

10 Breathing Exercises To Try When You’re Feeling Anxious

10 Ways To Beat Morning Fatigue

10 Type Of Squats You Can Do For Weight Loss

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS in England. This marks a significant advancement in the treatment of a condition that impacts an estimated 1.5 million women in the UK. The new drug, relugolix-estradiol-norethisterone (relugolix combination therapy or Ryeqo), offers a more comfortable and less stressful option compared to current treatments. But it will be accessible to only those patients who have already tried every alternative.Endometriosis is a long-term condition in which tissue that's like the womb lining grows somewhere else in the body, often in the pelvis, bladder, and bowel. This ectopic tissue, like normal endometrial tissue, thickens, breaks down, and bleeds during each menstrual cycle, but without a means of exit from the body. This activity causes intense inflammation, scarring, and the development of adhesions that can lead to intense pain and fertility issues.The condition is also legendary for its late diagnosis, with the majority of women taking nine years on average to receive an official diagnosis. Symptoms tend to be wrongly diagnosed as other conditions such as fibroids, pelvic inflammatory disease, or irritable bowel syndrome (IBS), so early detection is not always easy.Symptoms of endometriosis are likely to include:Severe period pain that interferes with daily lifeHeavy menstrual bleedingPainful urination or bowel movementsLower abdominal pain in a chronic formPainful sexFatigue and breathlessnessMood swings, anxiety, and depressionTrouble conceivingHow the New Pill Works?In contrast to existing injectable therapies that necessitate regular clinic visits, the newly approved pill provides a more convenient option for treating endometriosis at home. Relugolix combination therapy functions by inhibiting certain hormones that drive endometriosis growth while also offering required hormone replacement to offset side effects.Conventional injectable medications have the potential to aggravate symptoms initially before they bring relief, and thus complicate the treatment process for patients. Ryeqo works faster and reduces the use of multiple drugs, which streamlines the treatment process. Patients no longer need to visit hospitals and clinics repeatedly as they can take a pill daily. Physical as well as psychological stress is also minimized.Who Can Benefit from the New Treatment?Although promising, the new pill will only be offered to women who have already attempted and failed other medical or surgical interventions for endometriosis. It is predicted that about 1,000 women per year will receive this treatment on the NHS.Aside from addressing endometriosis, Ryeqo has also been approved by NICE for treating moderate to severe symptoms of uterine fibroids, another condition that affects numerous women.Helen Knight, NICE director of medicines evaluation, underlined the significance of this approval, saying, "This new treatment represents a potential step-change in the management of endometriosis, returning control to patients while maintaining value for the taxpayer."The release of this pill is a welcome relief, as women with endometriosis often have limited treatment options available to them. Today, managing the condition typically consists of pain killers, hormonal therapies, and, in extreme cases, operations like laparoscopies or hysterectomies.NHS national clinical director for women's health Dr. Sue Mann emphasized the pill's benefits, saying, "This first-of-a-kind treatment for endometriosis – a condition which can be hugely debilitating – will give women more control over their own health by potentially enabling them to receive the treatment they require in the privacy of their own homes, without the necessity of going to regular appointments."Cost and Availability of the PillThe treatment is priced at £72 for a 28-day supply (VAT excluded). Although the cost appears high, the long-term advantages of minimizing hospital consultations and enhancing patients' quality of life make it an economical intervention in the wider healthcare context.The pill will be accessible via standard NHS commissioning, thereby allowing those who qualify to use it without incurring extra financial costs.What This Means for Women's Health?The approval of Ryeqo is a welcome step in the right direction, but it also points to the continuing issues in endometriosis treatment. There are still many women who experience long delays in diagnosis and treatment, and there is an urgent need for more research, awareness, and funding for improved solutions.Although this new pill will not cure endometriosis, it is a step in the right direction for making the disease more manageable and enhancing the quality of life for thousands of women. As medicine develops further, the desire would be for treatments to be more inclusive and accessible, eventually leading to improved outcomes for those suffering from endometriosis.For women suffering from endometriosis, the approval of this new daily pill is a ray of hope. Reducing the necessity for the need of invasive procedures and numerous doctor visits, it enables patients to get in control of their well-being in a more convenient manner. Nevertheless, ongoing advocacy and studies have to be present to ensure that all women who suffer from the same condition get the care and treatment they need.